2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias

2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>

François Mach, Colin Baigent, Alberico L. Catapano et al. · European Heart Journal · 2019 · 8.9K citations · Full text

Medicine, Cardiology, Internal Medicine +17

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

Frank L.J. Visseren, François Mach, Yvo M. Smulders et al. · European Heart Journal · 2021 · 6.3K citations · Full text

Medicine, Cardiology, Preventive Medicine +15

2023 ESC Guidelines for the management of acute coronary syndromes

Robert A. Byrne, Xavier Rosselló, J J Coughlan et al. · European Heart Journal · 2023 · 4.5K citations · Full text

Medicine, Cardiology, Internal Medicine +14

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

Christopher P. Cannon, Michael A. Blazing, Robert P. Giugliano et al. · New England Journal of Medicine · 2015 · 4.4K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

The Lancet · 2005 · 3.3K citations

Medicine, Internal Medicine, Pharmacology +13